By Mark Schoeman One of Clear Point Health’s core lines of busin­­­ess is engaging key opinion leaders (KOLs) on behalf of pharmaceutical companies, to glean

By Mark Schoeman At this point, in the midst of a global pandemic, both medical science liaisons (MSLs) and commercial sales representatives are virtually unable

By Sima Marzban, MD, PhD, MPH The relationships between patients and healthcare providers and intermediaries  (healthcare providers, manufacturers, and insurers) have been transformed in recent

By Paul Meade Long gone are the days when you could walk into a medical practice, and get a ten-minute meeting with a physician to

By Mark Schoeman When this pandemic began, we understood that it was going to have a significant impact on the pharmaceutical industry, but we’re just

By Paul Meade, M.Sc, MPH In any scenario planning situation, you start by looking at the macro-drivers of change. In other words, what’s happening in the

By Paul Meade, M.Sc, MPH Those of us in the healthcare community always believed that there was going to be another pandemic. But the pandemic

Clear Point Health is proud to announce a new podcast aimed at educating healthcare stakeholders like hospitals and life sciences companies in the study of

By Brian Castle Over the last decade, healthcare providers have been consolidating at breakneck pace. A variety of factors have fueled the rise of so-called

by Kristen Smithwick Value-based care promises to deliver better healthcare for less money. For years, US healthcare providers and institutions have received payments for care services

By Paul Meade, M.Sc, MPH The COVID-19 pandemic has brought many changes to our lives. Some of these changes will be temporary in nature, while

By Brian Castle As my colleague, CPH founder Paul Meade, recently noted, there are many ways to identify your key customer segments and get insights

By Paul Meade, M.Sc, MPH The world is changing all too fast. Surviving in modern business means adapting and embracing new ways of doing things.